Suppr超能文献

格里菲斯素与日本脑炎病毒的糖基化蛋白(E蛋白和prM蛋白)结合,并抑制其感染。

Griffithsin binds to the glycosylated proteins (E and prM) of Japanese encephalitis virus and inhibit its infection.

作者信息

Ishag Hassan Z A, Li Chen, Wang Fengjuan, Mao Xiang

机构信息

College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, Jiangsu Province, China; College of Veterinary Sciences, Nyala University, Nyala, Sudan.

College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, Jiangsu Province, China.

出版信息

Virus Res. 2016 Apr 2;215:50-4. doi: 10.1016/j.virusres.2016.01.016. Epub 2016 Jan 25.

Abstract

Griffithsin (GRFT) is a broad-spectrum antiviral protein against several glycosylated viruses. In our previous publication, we have shown that GRFT exerted antiviral activity against Japanese encephalitis virus (JEV) infection. Herein, we further elucidated the mechanism by which GRFT inhibits JEV infection in BHK-21 cells. In vitro experiments using Pull-down assay and Co-immunoprecipitation (CO-IP) assay showed that GRFT binds to the JEV glycosylated viral proteins, specifically the enveloped (E) and premature (prM) glycoproteins. The binding of GRFT to the JEV was competitively inhibited by increasing concentrations of mannose; in turns abolished anti-JEV activity of GRFT. We suggested that, the binding of GRFT to the glycosylated viral proteins may contribute to its anti-JEV activity. Collectively, our data indicated a possible mechanism by which GRFT exerted its anti-JEV activity. This observation suggests GRFT's potentials in the development of therapeutics against JEV or other flavivirus infection.

摘要

格里菲斯菌素(GRFT)是一种针对多种糖基化病毒的广谱抗病毒蛋白。在我们之前的出版物中,我们已经表明GRFT对日本脑炎病毒(JEV)感染具有抗病毒活性。在此,我们进一步阐明了GRFT抑制BHK - 21细胞中JEV感染的机制。使用下拉分析和免疫共沉淀(CO - IP)分析的体外实验表明,GRFT与JEV糖基化病毒蛋白结合,特别是包膜(E)糖蛋白和前体(prM)糖蛋白。随着甘露糖浓度的增加,GRFT与JEV的结合受到竞争性抑制;进而消除了GRFT的抗JEV活性。我们认为,GRFT与糖基化病毒蛋白的结合可能有助于其抗JEV活性。总体而言,我们的数据表明了GRFT发挥其抗JEV活性的一种可能机制。这一观察结果表明GRFT在开发针对JEV或其他黄病毒感染的治疗方法方面具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba4/7114533/bede01db131b/gr1.jpg

相似文献

1
Griffithsin binds to the glycosylated proteins (E and prM) of Japanese encephalitis virus and inhibit its infection.
Virus Res. 2016 Apr 2;215:50-4. doi: 10.1016/j.virusres.2016.01.016. Epub 2016 Jan 25.
2
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.
Arch Virol. 2013 Feb;158(2):349-58. doi: 10.1007/s00705-012-1489-2. Epub 2012 Oct 7.
3
Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.
Virol Sin. 2013 Jun;28(3):152-60. doi: 10.1007/s12250-013-3331-8. Epub 2013 May 25.
5
Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo.
Antiviral Res. 2020 Feb;174:104673. doi: 10.1016/j.antiviral.2019.104673. Epub 2019 Dec 5.
6
Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
Antiviral Res. 2014 Apr;104:7-14. doi: 10.1016/j.antiviral.2014.01.011. Epub 2014 Jan 24.
8
Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Virology. 2008 Sep 15;379(1):143-51. doi: 10.1016/j.virol.2008.06.017. Epub 2008 Jul 21.
9
Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo.
Virology. 2014 Apr;454-455:48-59. doi: 10.1016/j.virol.2014.01.025. Epub 2014 Feb 22.

引用本文的文献

2
Natural products and derivatives as Japanese encephalitis virus antivirals.
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae022.
3
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
Microbiol Res. 2022 Dec;265:127206. doi: 10.1016/j.micres.2022.127206. Epub 2022 Sep 21.
4
Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses.
Mol Biol Rep. 2022 Dec;49(12):12239-12246. doi: 10.1007/s11033-022-07854-8. Epub 2022 Sep 22.
5
The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs.
Microorganisms. 2022 Jun 26;10(7):1294. doi: 10.3390/microorganisms10071294.
6
Lectins and lectibodies: potential promising antiviral agents.
Cell Mol Biol Lett. 2022 May 13;27(1):37. doi: 10.1186/s11658-022-00338-4.
8
Algal and Cyanobacterial Lectins and Their Antimicrobial Properties.
Mar Drugs. 2021 Dec 1;19(12):687. doi: 10.3390/md19120687.
9
Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections.
Pharmaceuticals (Basel). 2021 Aug 6;14(8):774. doi: 10.3390/ph14080774.
10
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
AAPS PharmSciTech. 2021 Feb 24;22(3):83. doi: 10.1208/s12249-021-01931-0.

本文引用的文献

1
Cellular DDX3 regulates Japanese encephalitis virus replication by interacting with viral un-translated regions.
Virology. 2014 Jan 20;449:70-81. doi: 10.1016/j.virol.2013.11.008. Epub 2013 Nov 26.
2
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.
Arch Virol. 2013 Feb;158(2):349-58. doi: 10.1007/s00705-012-1489-2. Epub 2012 Oct 7.
3
Griffithsin has antiviral activity against hepatitis C virus.
Antimicrob Agents Chemother. 2011 Nov;55(11):5159-67. doi: 10.1128/AAC.00633-11. Epub 2011 Sep 6.
4
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
J Virol. 2011 Sep;85(17):9039-50. doi: 10.1128/JVI.02675-10. Epub 2011 Jun 22.
6
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6099-104. doi: 10.1073/pnas.0901506106. Epub 2009 Mar 30.
8
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
J Med Primatol. 2007 Aug;36(4-5):244-53. doi: 10.1111/j.1600-0684.2007.00242.x.
9
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.
Nat Rev Microbiol. 2007 Aug;5(8):583-97. doi: 10.1038/nrmicro1707.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验